
Dexelvucitabine
CAS No. 134379-77-4
Dexelvucitabine ( beta-D-D-4FC | D-D-4FC | DFC | DPC-817 | RVT )
产品货号. M27870 CAS No. 134379-77-4
Dexlvucitabine 是一种核苷逆转录酶抑制剂,可用于治疗 HIV 感染。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2001 | 有现货 |
![]() ![]() |
10MG | ¥3216 | 有现货 |
![]() ![]() |
25MG | ¥5370 | 有现货 |
![]() ![]() |
50MG | ¥7655 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Dexelvucitabine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Dexlvucitabine 是一种核苷逆转录酶抑制剂,可用于治疗 HIV 感染。
-
产品描述Dexelvucitabine, a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.
-
体外实验——
-
体内实验Dexelvucitabine (Reverset; d-d4FC; 33.3 mg/kg by i.v. or p.o.) has distribution and elimination half-lives (t1/2α?and?t1/2β, respectively) of 0.7 and 3.6 hin monkeys, respectively. The Cmax ranges from 21.1 to 47.5 μM. Dexelvucitabine has a favorable pharmacokinetic profile with a long half-life (4.71 and 10.75 h after administration by the intravenous [i.v.] and oral [p.o.] routes, respectively)?in woodchucks.
-
同义词beta-D-D-4FC | D-D-4FC | DFC | DPC-817 | RVT
-
通路Microbiology/Virology
-
靶点Reverse Transcriptase
-
受体inflammation
-
研究领域——
-
适应症——
化学信息
-
CAS Number134379-77-4
-
分子量227.195
-
分子式C9H10FN3O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (220.08 mM)
-
SMILESNc1nc(=O)n(cc1F)[C@@H]1O[C@H](CO)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Park, Seul-Ki, Lee, Mi-Young. Inhibitory effects of chiisanoside and acanthoside on the allergic inflammation.Molecular and Cellular Toxicology, 2007, 3(4):60-60.